Systemic versus localized coagulation activation contributing to organ failure in critically ill patients.
about
In-line filtration minimizes organ dysfunction: new aspects from a prospective, randomized, controlled trialPlatelets protect from septic shock by inhibiting macrophage-dependent inflammation via the cyclooxygenase 1 signalling pathway.Thrombin contributes to protective immunity in pneumonia-derived sepsis via fibrin polymerization and platelet-neutrophil interactions.A non-lethal traumatic/hemorrhagic insult strongly modulates the compartment-specific PAI-1 response in the subsequent polymicrobial sepsis.Infection-associated platelet dysfunction of canine platelets detected in a flow chamber modelIn-line Filtration Decreases Systemic Inflammatory Response Syndrome, Renal and Hematologic Dysfunction in Pediatric Cardiac Intensive Care PatientsThe sepsis model: an emerging hypothesis for the lethality of inhalation anthraxShock induced endotheliopathy (SHINE) in acute critical illness - a unifying pathophysiologic mechanism.Tumour necrosis factor in infectious disease.Integrative model of leukocyte genomics and organ dysfunction in heart failure patients requiring mechanical circulatory support: a prospective observational study.Endothelial and Microcirculatory Function and Dysfunction in Sepsis.Thermoregulation as a disease tolerance defense strategy.Expression and Function of Granzymes A and B in Escherichia coli Peritonitis and Sepsis.Correlation between Interleukin-6 and Thrombin-Antithrombin III Complex Levels in Retinal Diseases.Coated-Platelet Trends Predict Short-Term Clinical OutcomeAfter Subarachnoid Hemorrhage.Activated Protein C has No Effect on Pulmonary Capillary Endothelial Function in Septic Patients with Acute Respiratory Distress Syndrome: Association of Endothelial Dysfunction with Mortality.
P2860
Q28394345-AF3AC2CB-7570-4EC8-A525-4C34B6E13C54Q33411077-7318F98B-188E-4D0B-A5B4-CD8D63E25DA6Q33438463-2C639D6C-D518-48FD-9142-D53BFA256428Q34586083-760C5654-7FF2-4EFD-A8FC-BF58310EC6AAQ34768373-329DDC4D-F6EF-4AD0-B623-0916292DD493Q35830927-5F180554-89CB-4629-9BC3-3F891A4574F3Q37060218-6D3CF100-4D07-461C-AF01-8FF591C7135DQ37633753-995CFDBE-0229-46F6-BA9F-93FE70BE5200Q38086506-68B3A6A9-B512-4927-8A99-FE4B2B28751BQ38429229-8512BCF0-7857-411D-82C5-2F0CDABEA370Q38845321-C1D382B2-8943-48C2-881F-02D493510105Q38999142-5D4E99D8-E208-4739-B910-085242C38014Q40140760-8A25E7F1-5871-466B-BAED-5430FF0A7C18Q45869007-889020BC-6410-4448-A88B-F7154DB35022Q47682950-A40BB927-D51D-4692-AE18-C697DB8E7F41Q52651073-47A26D6A-A304-401B-8ADE-33084697C5D2
P2860
Systemic versus localized coagulation activation contributing to organ failure in critically ill patients.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Systemic versus localized coag ...... re in critically ill patients.
@en
Systemic versus localized coag ...... re in critically ill patients.
@nl
type
label
Systemic versus localized coag ...... re in critically ill patients.
@en
Systemic versus localized coag ...... re in critically ill patients.
@nl
prefLabel
Systemic versus localized coag ...... re in critically ill patients.
@en
Systemic versus localized coag ...... re in critically ill patients.
@nl
P2860
P1476
Systemic versus localized coag ...... re in critically ill patients.
@en
P2093
Marcel Levi
P2860
P2888
P304
P356
10.1007/S00281-011-0283-7
P577
2011-07-30T00:00:00Z
2012-01-01T00:00:00Z